1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Chronic Subdural Hematoma Global Clinical Trials Review, H1, 2014

Chronic Subdural Hematoma Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Chronic Subdural Hematoma Global Clinical Trials Review, H1, 2014" provides data on the Chronic Subdural Hematoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chronic Subdural Hematoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chronic Subdural Hematoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Chronic Subdural Hematoma Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Chronic Subdural Hematoma 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Chronic Subdural Hematoma to Central Nervous System Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Chronic Subdural Hematoma to Central Nervous System Clinical Trials 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Unaccomplished Trials of Chronic Subdural Hematoma 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Chronic Subdural Hematoma Therapeutics Clinical Trials 25
Prominent Drugs 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
Octapharma AG 27
Clinical Trial Overview of Octapharma AG 27
Kantonsspital Aarau AG 28
Clinical Trial Overview of Kantonsspital Aarau AG 28
Clinical Trial Overview of Top Institutes / Government 29
Tianjin Medical University General Hospital 29
Clinical Trial Overview of Tianjin Medical University General Hospital 29
Ministry of Education, Culture, Sports, Science and Technology 30
Clinical Trial Overview of Ministry of Education, Culture, Sports, Science and Technology 30
Montpellier University Hospital 31
Clinical Trial Overview of Montpellier University Hospital 31
Addenbrooke's Hospital 32
Clinical Trial Overview of Addenbrooke's Hospital 32
Department of Neurosurgery, University Hospital 33
Clinical Trial Overview of Department of Neurosurgery, University Hospital 33
Saitama Medical University 34
Clinical Trial Overview of Saitama Medical University 34
Charite - Universitatsmedizin Berlin 35
Clinical Trial Overview of Charite - Universitatsmedizin Berlin 35
Eastern Virginia Medical School 36
Clinical Trial Overview of Eastern Virginia Medical School 36
University of Virginia 37
Clinical Trial Overview of University of Virginia 37
Islamic Azad University of Tabriz 38
Clinical Trial Overview of Islamic Azad University of Tabriz 38
Five Key Clinical Profiles 39
Appendix 58
Abbreviations 58
Definitions 58
Research Methodology 59
Secondary Research 59
About GlobalData 60
Contact Us 60
Disclaimer 60
Source 60

List of Tables
Chronic Subdural Hematoma Therapeutics, Global, Clinical Trials by Region, 2014* 6
Chronic Subdural Hematoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Chronic Subdural Hematoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Chronic Subdural Hematoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Chronic Subdural Hematoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Chronic Subdural Hematoma Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Chronic Subdural Hematoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Proportion of Chronic Subdural Hematoma to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13
Chronic Subdural Hematoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Chronic Subdural Hematoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Chronic Subdural Hematoma to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 16
Chronic Subdural Hematoma Therapeutics, Global, Clinical Trials by Phase, 2014* 17
Chronic Subdural Hematoma Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 18
Chronic Subdural Hematoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Chronic Subdural Hematoma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 20
Chronic Subdural Hematoma Therapeutics, Global, Terminated Clinical Trials, 2014* 21
Chronic Subdural Hematoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Chronic Subdural Hematoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 23
Chronic Subdural Hematoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
Chronic Subdural Hematoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 25
Chronic Subdural Hematoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
Chronic Subdural Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Octapharma AG, 2014* 27
Chronic Subdural Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Kantonsspital Aarau AG, 2014* 28
Chronic Subdural Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Tianjin Medical University General Hospital, 2014* 29
Chronic Subdural Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Ministry of Education, Culture, Sports, Science and Technology, 2014* 30
Chronic Subdural Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Montpellier University Hospital, 2014* 31
Chronic Subdural Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Addenbrooke's Hospital, 2014* 32
Chronic Subdural Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Neurosurgery, University Hospital, 2014* 33
Chronic Subdural Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Saitama Medical University, 2014* 34
Chronic Subdural Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite - Universitatsmedizin Berlin, 2014* 35
Chronic Subdural Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Virginia Medical School, 2014* 36
Chronic Subdural Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Virginia, 2014* 37
Chronic Subdural Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Islamic Azad University of Tabriz, 2014* 38

List of Figures
Chronic Subdural Hematoma Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Chronic Subdural Hematoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Chronic Subdural Hematoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Chronic Subdural Hematoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Chronic Subdural Hematoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Chronic Subdural Hematoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 12
Proportion of Chronic Subdural Hematoma to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13
Chronic Subdural Hematoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Chronic Subdural Hematoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Chronic Subdural Hematoma to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 16
Chronic Subdural Hematoma Therapeutics, Global, Clinical Trials by Phase (%), 2014* 17
Chronic Subdural Hematoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 18
Chronic Subdural Hematoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Chronic Subdural Hematoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Chronic Subdural Hematoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 23
Chronic Subdural Hematoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
Chronic Subdural Hematoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 25
Chronic Subdural Hematoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
GlobalData Methodology 59

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.